News | Artificial Intelligence | November 06, 2023

Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment 

Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment

(from left to right) Lunit's AI-powered chest X-ray analysis solution 'Lunit INSIGHT CXR' and AI-powered mammography analysis solution 'Lunit INSIGHT MMG'


November 6, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is set to unveil seven significant abstracts at the Radiological Society of North America (RSNA) 2023 Annual Meeting, taking place from November 26 to November 30 in Chicago. 

The highlighted abstracts for RSNA 2023 include: 

  • an oral presentation: Lunit's AI model redefines the efficiency of chest radiograph reporting by combining new and existing AI algorithms to filter normal chest radiographs and act as a safety net to reduce radiologists’ workload. 
  • an oral presentation: in collaboration with a Swedish research group, the accuracy and robustness metrics of Lunit INSIGHT MMG were assessed in comparison to radiologists. 
  • an ePoster: Lunit's novel, predictive AI model goes beyond traditional mammographic density by investigating mammographic parenchymal patterns and longitudinal changes as predictive markers for breast cancer risk. 
  • an ePoster: comparison of the diagnostic accuracy of radiologists with and without Lunit’s AI-powered breast cancer screening solution. 
  • an ePoster: assessment of the value of supplemental breast ultrasound and Lunit’s AI in screening mammography for women with dense breasts. 
  • an ePoster: assessment of the false-negative results of Lunit’s AI-based CADe/x in mammograms for invasive breast cancers, considering molecular subtypes. 

"Lunit is consistently backing the effectiveness of the Lunit INSIGHT suite by participating in RSNA and unveiling a spectrum of innovative research results each year at RSNA since 2016. We remain dedicated to enhancing our solutions, steering the field towards a new era of chest and breast cancer screening," said Brandon Suh, CEO of Lunit. 

Beyond abstract presentations, Lunit will further showcase its AI solutions onsite by setting up a dedicated booth (#4165) at the AI Showcase section. Visitors will have the opportunity to experience firsthand how Lunit’s AI solutions are contributing to more than 2000 medical institutions worldwide and addressing the most significant global health challenges. 

For more information: www.lunit.com 

 

Find more RSNA23 conference coverage here 

 

Related content: 

Lunit SCOPE IO Enhances Breast Cancer Analysis and Treatment by Accurately Assessing Tumor-Infiltrating Lymphocytes 

Lunit's AI-Powered Mammography Analysis Solution Achieves Comparable Diagnostic Performance with Human Readers 

STUDY VALIDATES LUNIT AI AS A GAME-CHANGER, POISED TO REPLACE ONE HUMAN READER IN BREAST CANCER SCREENING 


Related Content

News | Digital Pathology

June 15, 2026 — Leica Biosystems is expanding the availability of its Aperio GT Elite digital scanner into the EMEA ...

Time June 15, 2026
arrow
News | Information Technology

June 9, 2026 — Mosaic Clinical Technologies, a wholly owned subsidiary of Radiology Partners, has launched Mosaic ...

Time June 15, 2026
arrow
News | Imaging Software Development

June 10, 2026 — DeepHealth, Inc., a wholly owned subsidiary of RadNet, has launched Reporting Pro, an AI-powered ...

Time June 12, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
Subscribe Now